Skip to content

Kabasura Kudineer, Shakti drops and Turmeric plus in the management of COVID-19

A clinical study to evaluate the effect of AYUSH medicines in the management of COVID-19

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026371
Enrollment
30
Registered
2020-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: 1.Kabasura kudineer 2.Shakti Drops 3.Turmeric plus tablets: 1.Kabasura kudineer 2 tablets taken thrice a day before food 2.Shakti Drops â?? 6 drops with 100 ml of water thrice a day bef

Sponsors

Sriveda Sattva Private Limited Sri Sri Tattva
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age limit â?? 20 to 55 years, both Male &Female 2. Uncomplicated cases of COVID19 patients on Allopathic medication of stage 1 and stage 2 3. Patients whom ventilator support is not required 4. Patients with no associated comorbidities 5.patientswillingtogivetheirconsenttoparticipateintheclinicaltrial

Exclusion criteria

Exclusion criteria: 1. COVID-19 positive patients above 55 years of age & below 20years 2. Patients with associated comorbidities like hypertension, type 2 or type 1 diabetes or chronic or acute renal failure or pre -existing cardiac conditions. 3. Patients on immuno-suppression therapy 4. Pregnant Women or lactating mothers

Design outcomes

Primary

MeasureTime frame
Early recovery in the signs and symptoms of cases of stage 1 and stage 2 of COVID-19 by adding Ayurvedic medicines which are effective in fever, symptoms of respiratory tract and by enhancing immunity of body by adding Rasayana drugsTimepoint: 1,14,21 and 28 the day

Secondary

MeasureTime frame
Improvement of quality life of cases of stage 1 and stage 2 of COVID-19Timepoint: 1 and 28 th day

Countries

India

Contacts

Public ContactDr M Ravi Kumar Reddy

Mazumder Shaw Medical Centre Narayana Hrudayalaya, Bangalore

rrpulmo@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026